OptimizeRx OPRX
NASDAQ OPRX
$7.87 -0.08 (-1.01%)
At close: Sep 4, 2026 · 4:00 PM EDT

OptimizeRx (OPRX) Notes Payables (2019 - 2020)

OptimizeRx's (OPRX) quarterly Notes Payables came in at $285795.0 in Q4 2020, down 50.73% year-over-year from $580014.0 in Q1 2020, and down 50.73% quarter-over-quarter from $580014.0 in Q4 2019.

Analysis

OptimizeRx (OPRX) Notes Payables (2019 - 2020) Analysis & Trends

OptimizeRx has disclosed Notes Payables across 2 years of filings, most recently posting $285795.0 for Q4 2020.

  • In Q4 2020, Notes Payables fell 50.73% year-over-year to $285795.0; the TTM figure through Dec 2020 stood at $285795.0 (down 50.73% YoY), while the FY2020 annual figure was $285795.0, down 50.73% from the prior year.
  • Notes Payables came in at $285795.0 for Q4 2020 at OptimizeRx, down from $580014.0 in the prior quarter.
  • In the past five years, Notes Payables ranged from a high of $580014.0 in Q4 2019 to a low of $285795.0 in Q4 2020.
Peer Set

Peer Comparison

# Company Market Cap Enterprise Value Gross Profit (Qtr)
1 Veeva Systems 44.53 Bn 37.29 Bn 695.95 Mn
2 Waystar Holding 4.81 Bn 4.62 Bn 221.99 Mn
3 Doximity 4.74 Bn 4.05 Bn 132.93 Mn
4 CCC Intelligent Solutions Holdings 4.41 Bn 4.30 Bn 210.64 Mn
5 EverCommerce 1.40 Bn 1.27 Bn 119.50 Mn
6 Schrodinger 1.32 Bn 904.47 Mn 32.43 Mn
7 Certara 1.21 Bn 1.03 Bn 58.15 Mn
8 GoodRx Holdings 1.18 Bn 887.53 Mn 179.41 Mn
9 Healthstream 853.81 Mn 787.08 Mn 54.72 Mn
10 OptimizeRx 148.24 Mn 124.14 Mn 15.69 Mn
Historic Data

Historic Data

Download Data
DateValue
Dec 31, 2020 285,795.00
Dec 31, 2019 580,014.00